Cox regression analysis of CD33 expression (Q1-3 vs Q4) and other prognostic factors
| . | Univariate . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OS from study entry . | OS from CR . | DFS from CR . | |||||||||
| n . | HR . | 95% CI . | P . | n . | HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
| CD33 expression | |||||||||||
| Q1-3 | 188 | 1 | 150 | ||||||||
| Q4 | 50 | 1.55 | 0.96-2.50 | .075 | 40 | 2.35 | 1.35-4.09 | .002 | 1.74 | 1.08-2.82 | .022 |
| Risk group (cyto/mutation) | |||||||||||
| Standard | 116 | 1 | 87 | 1 | 1 | ||||||
| Low | 79 | 0.37 | 0.21-0.68 | .001 | 69 | 0.44 | 0.22-0.88 | .02 | 0.65 | 0.39-1.08 | .094 |
| High | 26 | 1.67 | 0.94-2.99 | .083 | 19 | 1.97 | 0.95-4.05 | .067 | 1.5 | 0.77-2.93 | .232 |
| . | Univariate . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OS from study entry . | OS from CR . | DFS from CR . | |||||||||
| n . | HR . | 95% CI . | P . | n . | HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
| CD33 expression | |||||||||||
| Q1-3 | 188 | 1 | 150 | ||||||||
| Q4 | 50 | 1.55 | 0.96-2.50 | .075 | 40 | 2.35 | 1.35-4.09 | .002 | 1.74 | 1.08-2.82 | .022 |
| Risk group (cyto/mutation) | |||||||||||
| Standard | 116 | 1 | 87 | 1 | 1 | ||||||
| Low | 79 | 0.37 | 0.21-0.68 | .001 | 69 | 0.44 | 0.22-0.88 | .02 | 0.65 | 0.39-1.08 | .094 |
| High | 26 | 1.67 | 0.94-2.99 | .083 | 19 | 1.97 | 0.95-4.05 | .067 | 1.5 | 0.77-2.93 | .232 |